Investigational treatments of COVID-19 in children


What The Study Did: This pharmacokinetic simulation study estimates appropriate pediatric-specific dosing regimens for hydroxychloroquine and remdesivir in the treatment of pediatric patients with COVID-19.

Authors: Michael Cohen-Wolkowiez, M.D., Ph.D., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.


Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.